<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article22</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/VA_Cooperative_Study" style="display:block; margin-bottom:10px;">VA Cooperative Study Original</a></li>
<h2><strong>VA Cooperative Study</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Aspirin in Unstable Angina Trial"<br/>
The New England Journal of Medicine. 1983. 309(7):396-403.<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
1 Clinical Question<br/>
2 Bottom Line<br/>
3 Major Points<br/>
4 Guidelines<br/>
5 Design<br/>
6 Population<br/>
6.1 Inclusion Criteria<br/>
6.2 Exclusion Criteria<br/>
6.3 Baseline Characteristics<br/>
7 Interventions<br/>
8 Outcomes<br/>
8.1 Primary Outcomes<br/>
8.2 Secondary Outcomes<br/>
9 Funding<br/>
10 Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In men with unstable angina, does treatment with aspirin reduce the risk of death or acute myocardial infarction?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In men with unstable angina, treatment with aspirin for 12 weeks led to a 51% reduction in the risk of death or acute myocardial infarction compared to placebo.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
Unstable angina is a condition with an increased risk of acute myocardial infarction and death. Prior to this study, the utility of aspirin in the management of unstable angina was not well defined.<br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
Current guidelines were not influenced by this trial since it was conducted prior to the establishment of modern guideline processes.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, double-blind, placebo-controlled, randomized trial.<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Total number of participants: 1266 men<br/>
<br/>
Inclusion Criteria<br/>
- Men with unstable angina<br/>
<br/>
Exclusion Criteria<br/>
- Women were not included in this trial<br/>
<br/>
Baseline Characteristics<br/>
- Men with unstable angina with various baseline characteristics.<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- Aspirin 324 mg in buffered solution daily for 12 weeks (n=625)<br/>
- Placebo (n=641)<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcomes<br/>
- Combined incidence of death or acute myocardial infarction after 12 weeks: 5.0% in the aspirin group vs. 10.1% in the placebo group (51% reduction; P = 0.0005).<br/>
<br/>
Secondary Outcomes<br/>
- Incidence of nonfatal acute myocardial infarction: 3.4% in the aspirin group compared to 6.9% in the placebo group (51% reduction; P = 0.005).<br/>
- Reduction in mortality: 1.6% in the aspirin group compared to 3.3% in the placebo group (51% reduction; not statistically significant; P = 0.054).<br/>
- No significant difference in gastrointestinal symptoms or blood loss between groups.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Not specified.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
Original publication in The New England Journal of Medicine (1983) 309:396â€“403.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
